Mono Pharmacare promoters declare no share encumbrance in FY26
Mono Pharmacare Limited's promoters and Persons Acting in Concert confirmed they did not create any encumbrance on shares during the financial year ended March 31, 2026. The disclosure was filed with the National Stock Exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
*this image is generated using AI for illustrative purposes only.
Mono Pharmacare Limited disclosed that its promoters and Persons Acting in Concert have not created any encumbrance on the company's shares during the financial year ended March 31, 2026. The declaration, submitted to the National Stock Exchange of India Limited, confirms that no shares were pledged directly or indirectly by the promoter group throughout the period.
The filing was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation mandates periodic disclosures regarding any encumbrance created by promoters or Persons Acting in Concert over the shares of the company. The confirmation provides assurance to shareholders regarding the unencumbered status of the promoter holding.
The disclosure was signed by Panilam Lakhatariya, a Promoter, on behalf of all Promoters and Persons Acting in Concert. The document was digitally signed on July 9, 2026, and addressed to the Listing Department of the National Stock Exchange of India Limited. A copy of the declaration was also marked to the Audit Committee of Mono Pharmacare .
| Detail | Information |
|---|---|
| Company Name | Mono Pharmacare Limited |
| NSE Symbol | MONOPHARMA |
| Regulation | SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |
| Financial Year Ended | March 31, 2026 |
| Encumbrance Status | No encumbrance made |
| Filing Date | July 9, 2026 |
Historical Stock Returns for Mono Pharmacare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.50% | -4.33% | -10.36% | +5.29% | -57.11% | -67.32% |
How will the unencumbered status of promoter holdings influence investor confidence and stock liquidity in the upcoming quarter?
Does this financial stability position Mono Pharmacare to pursue new acquisitions or expansion opportunities in the near future?
What are the expected capital allocation strategies given the absence of pledged shares and potential financial flexibility?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
